For Scientist-Entrepreneurs: You'll Need A Lot More Than Persistence To Survive

The entrepreneurial inventor involved in the start-up of a company would benefit from a careful reading of the article titled “Seed Money Blossoming Again For Entrepreneurs“ (The Scientist, June 22, 1992, page 1). There are a lot of good lessons in it. As a scientist and inventor (of a chemical calculator) I, like biotech entrepreneur Anthony Guiseppi-Elie, who was quoted in the article, have found that investors “no longer [have] an interest in funding a bright entrepreneur s

Written byBert Ramsay
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The entrepreneurial inventor involved in the start-up of a company would benefit from a careful reading of the article titled “Seed Money Blossoming Again For Entrepreneurs“ (The Scientist, June 22, 1992, page 1). There are a lot of good lessons in it. As a scientist and inventor (of a chemical calculator) I, like biotech entrepreneur Anthony Guiseppi-Elie, who was quoted in the article, have found that investors “no longer [have] an interest in funding a bright entrepreneur simply because he has a good product idea“ and that they tend to notice you only when you reach that “million dollars in sales“ level. I am pleased that Guiseppi-Elie's persistence paid off; after numerous rejections by venture capital people, his firm was able to survive, thanks to a $150,000 investment from the Ben Franklin Partnership Program. However, while I agree with hirn that persistence is very important in attracting venture capital, persistence ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies